Cannonau (CNNC) Stock Price, News & Analysis
Company Description
Cannonau (OTC Link: CNNC) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $48.3K.
CNNC has gained 200.0% over the past year. Shares last traded at $0.0003.
For FY2023, Cannonau reported net income of $338K.
This page collects what Stock Titan holds for CNNC, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Cannonau (CNNC) stock last closed at $0.0003. Over the past 12 months, the stock has gained 200.0%. At a market capitalization of $48.3K, CNNC is classified as a micro-cap stock with approximately 241.4M shares outstanding.
Latest News
Cannonau has 8 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 0 with negative movement. View all CNNC news →
SEC Filings
Financial Highlights
operating income reached -$30K, and net income was $338K. The company generated -$32K in operating cash flow. With a current ratio of 0.02, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Days to Cover History
CNNC Company Profile & Sector Positioning
Cannonau (CNNC) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing CNNC often look at related companies in the same sector, including Owc Pharmaceutical Resh Corp (OWCP), Hero Technologies Inc (HENC), Emergent Health (EMGE), Cannabis Stratgc (NUGS), and Western Sierra R (WSRC). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CNNC's relative position within its industry.